Advances in Lung Diseases of Neonatal Medicine
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: closed (30 June 2024) | Viewed by 6939
Special Issue Editor
Interests: bronchopulmonary dysplasia; patent ductus arteriosus; preterm infants
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Infants sometimes suffer from several lung diseases during their neonatal life, such as transient tachypnea of the newborn (TTNB), respiratory distress syndrome (RDS), meconium aspiration syndrome (MAS), pneumonia, pneumothorax, congenital diaphragmatic hernia (CDH), and bronchopulmonary dysplasia (BPD). Despite significant advances in perinatal and neonatal medicines, physicians and researchers are still trying to improve neonatal mortality and morbidities, potentially affecting both short- and long-term pulmonary outcomes in adulthood, using new techniques including new methods of surfactant administration for RDS, fetal therapy for CDH, and cell therapies for BPD.
We invite investigators to contribute original research as well as review articles addressing recent advances in lung diseases of neonatal medicine and their effects on both short-term and long-term pulmonary outcomes in children, adolescents, and adults. At the same time, research regarding the understanding of molecular mechanisms based on pharmacological treatments is welcome. We invite the submission of original, high-quality contributions that are not yet published or that are not currently under review by other journals or peer-reviewed conferences.
Dr. Fumihiko Namba
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bronchopulmonary dysplasia
- patent ductus arteriosus
- lung diseases of pediatrics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.